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Summary: Cancer survival comparisons between cohorts are often assessed by estimates of relative or net survival.
These measure the difference in mortality between those diagnosed with the disease and the general population.
For such comparisons methods are needed to standardize cohort structure (including age at diagnosis) and all-cause
mortality rates in the general population. Standardized non-parametric relative survival measures are evaluated by
determining how well they (i) ensure the correct rank ordering, (ii) allow for differences in covariate distributions, and
(iii) possess robustness and maximal estimation precision. Two relative survival families that subsume the Ederer-I,
Ederer-II and Pohar-Perme statistics are assessed. The aforementioned statistics do not meet our criteria, and are
not invariant under a change of covariate distribution. Existing methods for standardization of these statistics are
either not invariant to changes in the general population mortality or are not robust. Standardized statistics and
estimators are developed to address the deficiencies. They use a reference distribution for covariates such as age, and
a reference population mortality survival distribution that is recommended to approach zero with increasing age as
fast as the cohort with the worst life expectancy. Estimators are compared using a breast-cancer survival example
and computer simulation. The proposals are invariant and robust, and out-perform current methods to standardize
the Ederer-II and Pohar-Perme estimators in simulations, particularly for extended follow-up.
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1. Introduction
When cause of death is unavailable or unreliable it is not possible to directly estimate disease-
specific survival. For this reason, disease-specific survival is sometimes assessed by a measure
of the relative survival between a group diagnosed with disease and the wider population.
The main use of relative survival analysis is to compare survival between cohorts, such as
from different countries or over periods in time. A complication is that cohort structures can
differ. For example, relative survival in cancer is often lower for older patients than younger
patients, and different countries may have different distributions of age-at-diagnosis. In this
article we compare the use of relative survival measures for making such comparisons by
defining general criteria based on the following setup.
Let S be a survival function and Λ the corresponding cumulative hazard, with superscript
C denoting a cohort of interest (often patients diagnosed with cancer), and P the general
population from which the cohort was derived. We assume that survival may depend on
covariates x, including in particular age and gender. Then
Λe(t | x) = ΛC(t | x)− ΛP (t | x)
is defined to be the conditional excess cumulative hazard at time t, although Λe need not be
monotone or even positive. Typically t is time from diagnosis and ΛP (t | x) = ΛPb (a+ t | x),
where ΛPb is the cumulative hazard from birth and a is the age at diagnosis. Corresponding
to Λe
Se(t | x) = SC(t | x)/SP (t | x)
is the conditional relative survival (which may not be a survival function).
The initial estimators developed by Ederer and co-workers focused on the relative survival
EH{SC(t | X)}/EH{SP (t | X)}, where H is the marginal distribution of X, and EH denotes
expectations with respect to H (Ederer and Heise, 1959; Ederer et al., 1961). Este`ve et al.
(1990) suggested that when Se depends on x, the target of estimation should instead be the
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marginal net survival
Snet(t) = EH{Se(t | X)}
=
∫
Se(t | x)dH(x). (1)
When the relative survival is homogeneous, i.e. Se(t | x) = Se(t), then the Ederer estimators
are consistent for the marginal net survival. However, Este`ve et al. (1990) pointed out that
when the relative survival is heterogeneous the limit of the classical estimators depends on
the survival in the general population P , and so they are not universal. They suggested
modelling the excess hazard parametrically. Sasieni (1996) showed how it could be modelled
semi-parametrically, but it was not until Perme et al. (2012) that a non-parametric estimator
of the net survival corresponding to the marginal excess hazard was developed. Unlike
the classical methods, the Pohar-Perme estimator is consistent for the net survival (1) in
the heterogeneous setting and consequently Roche et al. (2013) suggested that all classical
methods should be abandoned. Lambert et al. (2015) noted a trade-off between consistency
of the new estimator and its precision.
We are not convinced that the mean of the relative conditional survival is the only statistic
of interest for the comparison of survival between countries, periods in time or types of
disease. Indeed, it is clear that the net survival depends on the covariate distribution, and
two populations with different such distributions may have different marginal net survivals,
even when the conditional net survival functions are identical. We next take a step back
from focus on the net survival, by considering what features one would like a covariate-free
descriptor of the relative survival to hold.
2. Criteria
Consider a functional R of two conditional survival functions and a covariate distribution
that is a function of time t only (i.e. R is not a function of covariates x), which describes
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the ratio of survival functions. For example, R might be the net survival:
R(SC , SP , H)(t) = EH{SC(t | X)/SP (t | X)},
or it could be the relative survival:
R(SC , SP , H)(t) = EH{SC(t | X)}/EH{SP (t | X)}.
If the purpose is to recreate the ratio of survival functions when they are independent of
covariates then this should be a requirement: R(SC , SP , H)(t) = SC(t)/SP (t) whenever
SC(t | x) = SC(t) and SP (t | x) = SP (t) for all x. More generally we might require this
to hold provided only that the ratio of survival functions Se (or equivalently the excess
cumulative hazard Λe) is independent of covariates. This is our first requirement:
A1 R(SC , SP , H)(t) = Se(t) whenever SC(t | x)/SP (t | x) = Se(t).
Se may be independent of covariates in real data. For example, relative survival from
advanced breast cancer in Section 6 appears to be approximately independent of age at
diagnosis until t = 10 years. When the ratio is not independent of covariates (A1 is vacuous,
but) we would still like the statistic to reflect the ordering of the ratio.
A2a If for some T , SC(t | x)/SP (t | x) 6 SC∗(t | x)/SP ∗(t | x) for all x and t 6 T , then
R(SC , SP , H)(t) 6 R(SC∗ , SP ∗ , H)(t) for all t 6 T .
A2b If for some T , SC(t | x)/SP (t | x) = SC∗(t | x)/SP ∗(t | x) for all x and t 6 T , then
R(SC , SP , H)(t) = R(SC
∗
, SP
∗
, H)(t) for all t 6 T .
A2c If for some T , SC(t | x)/SP (t | x) < SC∗(t | x)/SP ∗(t | x) for all x and t 6 T , then
R(SC , SP , H)(t) < R(SC
∗
, SP
∗
, H)(t) for all t 6 T .
Condition A2b is key for comparing relative survival between cohorts. It ensures that R does
not depend on SP other than through Se. Ideally we would like R to depend on SC and SP
only through their ratio even if the covariate distribution is different. This leads to our third
requirement, that the statistic is independent of the covariate distribution
4 Biometrics, X 2006
A3 R(SC , SP , H)(t) = R(SC , SP , H∗)(t).
When both A3 and A2b are satisfied, if SC(t | x)/SP (t | x) = SC∗(t | x)/SP ∗(t | x) for all x,
then R(SC , SP , H)(t) = R(SC
∗
, SP
∗
, H∗)(t). One reason for considering different statistics
other than the net survival (1) is that the net survival does not satisfy A3.
Conditions A1 and A2 might be considered essential for a descriptive measure of relative
survival, whereas A3 is necessary only for comparing relative survival between cohorts with
different covariate distributions. By analogy, the crude rate is useful for describing a single
cohort, but the age-standardized rate is more useful when comparing two cohorts.
If a measure meets criteria A1-A3 then we might ask what additional properties would be
desirable. We consider the following.
A4 Robustness. Small changes in SC for a fixed SP and H do not cause large changes in R.
A5 Precision. We prefer measures with smaller var(Rˆ)R−2, where Rˆ is an efficient estimator
of R.
3. Some relative survival families and estimators
The observable data for individuals i = 1, . . . , n are (Ti, Xi), where Ti is the time of death
and Xi the covariate value; P (Ti > t | xi) = SC(t | xi), X ∼ H; SPi (·) is assumed known.
If (SˆC , Hˆ) denote empirical versions of (SC , H) (putting mass 1/n at each point (Ti, Xi)),
then corresponding to a measure R(SC , SP , H) we may have an estimator R(SˆC , SP , Hˆ). To
allow for right censoring we follow Andersen et al. (1996) and use notation for the at-risk
process Yi(t) = I(Ti > t, not censored before t), where I(·) is the indicator function; and the
counting process Ni(t) =
∫ t
0 dNi(u) where dNi(t) = Yi(t)I(Ti = t).
Now, under independent censoring, consider a family of estimators of the cumulative excess
hazard
Aˆw(t) =
∫ t
0
∑n
i=1 wi(u)Yi(u){dNi(u)− dΛPi (u)}∑n
i=1wi(u)Yi(u)
, (2)
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where ΛPi is the cumulative hazard for an individual with covariate xi in the general popu-
lation, and wi(t) is a chosen weight given to the ith individual at time t, that may depend
on xi. Setting wi(t) = 1 for all i = 1, . . . , n and t > 0 yields the Ederer-II estimator of
the cumulative excess hazard (Aˆ1) (Ederer and Heise, 1959), and setting wi(t) = {SPi (t)}−1
provides the Pohar-Perme estimator (Aˆ1/SP ) (Perme et al., 2012). They may be put onto a
survival scale through the usual transformation exp{−Aˆw(t)}. Since Y (u | X)dN(u | X) =
dN(u | X), E{N(u | X) | X} = 1−SC(u | X) and E{Y (u | X)} = SC(u | X), we may write
Aˆw(t) =
∫ t
0
EHˆ [w(u,X){dSˆC(u | X)− SˆC(u | X)dΛP (u | X)}]
EHˆ{w(u,X)SˆC(u | X)}
.
It follows that if the Xi are independent and identically distributed then Aˆw(t) converges to∫ t
0
EH [w(u,X){dSC(u | X)− SC(u | X)dΛP (u | X)}]
EH{w(u,X)SC(u | X)} ,
and because −dSC/SC = dΛC
Aw(t) =
∫ t
0
EH [w(u,X)S
C(u,X){dΛC(u | X)− dΛP (u | X)}]
EH{w(u,X)SC(u | X)} .
This leads to our first family of relative survival measures:
R1w(S
C , SP , H) = exp{−Aw(t)} (weighted excess hazards).
A second family is defined
R2w(S
C , CP , H) =
EH{w(t,X)SC(t | X)}
EH{w(t,X)SP (t | X)} (relative weighted survival).
If w(t,X) = 1 then we have the limit of the Ederer-I estimator (Ederer et al., 1961). Relative
weighted survival satisfies our criterion A1 because in this case
EH{w(t,X)SC(t | X)} = Se(t)EH{w(t,X)SP (t | X)}.
In order for it to satisfy A2, and depend only on Se and not SP , the weight w(t,X) =
v(t,X)/SP (t) where v(t,X) is a weight function that does not depend on SP (t). Since R21/SP
is the net survival, we call R2v/SP weighted net survival.
There is a natural family of estimators corresponding to R2w that, to our knowledge, has
6 Biometrics, X 2006
been not been used previously. When there is no censoring then R2w may be estimated
consistently by ∑n
i=1 wi(t)Y
+
i (t)∑n
i=1wi(t)S
P
i (t)
, (3)
where Y +i (t) = I(Ti > t). For the more general case with censoring D that is independent
of the covariate (so that SDi = S
D), we can define a family of estimators for R2w as
Uw(t) =
∑n
i=1wi(t)Y
+
i (t)
SˆD(t)
∑n
i=1wi(t)S
P
i (t)
, (4)
where SˆD(t) is a Kaplan-Meier estimate of the censoring survival distribution. When w(t, x) =
1 we have Ederer-I and when w(t, x) = 1/SP (t | x) we have an alternative to the Pohar-Perme
estimator that is also consistent for the net survival. Further, when there is no competing
mortality so that SPi (t) = 1 for all i and t, then Rˆ1 = Rˆ1/SP and U1 = U1/SP , and it can
be shown that U1(t) = Rˆ
1
1(t), with both equal to the Kaplan-Meier estimate of S
C(t) in the
cohort (which is the non-parametric maximum likelihood estimate).
We end by imposing some restrictions on the weights w(t, x) based on the criteria. By
definition the first two arguments to each R may be stated in terms of any two of SC , SP
and Se. If we consider R as a function of (SP , Se, H), then A2a and A3 imply that it depends
only on Se. Suppose that Rw′ satisfied A2a and A3 and that w = w
′v, then for Rw to also
satisfy A2a and A3 v should depend on (SP , Se, H) only via Se.
4. Assessment of criteria
We next consider whether the families R1w and R
2
w satisfy our fundamental requirements
A1-A3.
A1 Both R1w and R
2
w satisfy A1. This is seen by taking the excess terms such as S
e outside
of the expectation.
A2 When w(t, x) = v(t, x)/SP (t | x) and v(t, x) depends on (SC , SP , H) only through Se (or
not at all) then both R1w and R
2
w satisfy A2. It is for this reason that the limit of the
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Ederer-I and Ederer-II estimators do not satisfy A2: they depend on SP even when Se is
fixed.
A3 Neither R1w nor R
2
w are guaranteed to satisfy A3. In order for them to do so one needs
to standardize so that the weights are proportional to the ratio of the standardized to the
observed covariate density, i.e. h0(x)/h(x), using the superscript 0 to denote a standard
population. This is the approach to age adjustment that was proposed by Brenner et al.
(2004); see Section 5.2 for further discussion. If we wish to standardize two cohorts with
covariate distributions H and H∗ that do not have the same support, then to meet A3 the
support of the standard distribution H0 should be their intersection only (i.e. h0(X) = 0
if either h(X) = 0 or h∗(X) = 0).
We have thus established that R1w and R
2
w satisfy our main requirements A1-A3 provided
w(t, x) = h0(x)v(t, x)/{SP (t | x)h(x)} and v(t, x) depends on (SC , SP , H) only via Se.
A4 Assuming w = h0v/(hSP ) then R1w(t) becomes
exp
[
−
∫ t
0
EH0{v(u,X)Se(u | X)dΛe(u | X)}
EH0{v(u,X)Se(u | X)}
]
,
and R2w(t) becomes
EH0{v(t,X)Se(t | X)}
EH0{v(t,X)} .
It is then clear that in order for R1w and R
2
w to be robust (against for instance a very
large |dΛe(u | Xi)| which might happen in a sample when SC is very small), one should
require that w(u, x) is bounded for all u and x. When w = h0v/(hSP ) then this can
either be achieved by setting h0(x) = 0 when SP is very small (compared with other
x at the same t) or ensuring that v/SP is bounded. Further, consider SC∆ such that
|SC∆(t | x)−SC(t | x)| 6 ∆ for all t and x and SC∆(t | x) = SC(t | x)−∆ for tl < t < tu,
some x and small constant ∆ > 0 where SC(t∗ | x) =  > ∆ for some t∗ ∈ (tl, tu). Then
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assuming the hazards exist
λC(t∗ | x) = −dS
C(t∗ | x)/dt

λC∆(t∗ | x) = −dS
C(t∗ | x)/dt
−∆
and
λC∆(t∗ | x)
λC(t∗ | x) =
−∆

.
Thus for fixed ∆, as t gets large so that SC(t | x) =  gets small, λC∆(t | x) may be
substantially different from λC(t | x), which affects the excess hazard (for fixed SP ). In
other words R1w and R
2
w are not robust unless w is carefully chosen: for each x, the weights
w(t, x)SC(t, x)/EH{w(t,X)SC(t | X)} need to approach zero with t as fast or faster than
SP (t | x). This argument is also relevant for comparisons between populations: to be
robust w(t, x)/EH{w(t, x)} should approach zero as fast or faster than SP (t | x) in all
populations compared. Recall that if a is age at diagnosis, then SP (t | a) = SPb (t + a)
where SPb (t) is the probability of living until age t in the general population.
A5 The asymptotic variance of Rˆ1w may be estimated by Rˆ
1
w(t)σˆ
2(t) using the same arguments
as Perme et al. (2012) where
σˆ2(t) =
∫ t
0
J(u)
∑n
i=1 dNi(u)w
2
i (u)
{∑ni=1 Yi(u)wi(u)}2 , (5)
with J(t) = I{∑ni=1 Yi(t) > 0}.
The variance of the estimator of R2w(t) in (3) is∑n
i=1w
2
i S
C
i (1− SCi )
(
∑n
i=1wiS
P
i )
2
. (6)
It is not straightforward to use this formula for estimation because of the difficulty in
estimating SCi without modelling its dependence on X. Although E{Y +i (t)} = SCi (t),
Y +i (t) ∈ {0, 1} so we cannot in general simply replace SCi in (6) by Y +i . One exception
is when there are assumed to be j = 1, . . . , k homogeneous groups of size nj. Then, with
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independent censoring within each strata one may estimate R2w as∑k
j=1 njwj(t)Sˆ
C
j (t)∑k
j=1 njwj(t)S
P
j (t)
,
based on a stratum-specific Kaplan-Meier estimate SˆCj (t), and the variance may be esti-
mated via ∑k
j=1 njw
2
jvar(Sˆ
C
j )
(
∑k
j=1 njwjS
P
j )
2
,
where Greenwood’s formula might be used for var(SˆCj ). However, in practice a bootstrap
estimate of the variance of Uw is recommended because one may avoid the assumption of
homogeneous groups.
Precision of the estimators of R1w and R
2
w is clearly affected by the choice of weight
function due to the w2i term in the numerator of the variance. In both, functions that
place more weight on the oldest patients, such as wi(t) = 1/S
P
i (t) (Pohar-Perme with
R1w) are less precise than others with weights such as wi(t) = 1 (Ederer-II with R
1
w), or
wi(t) = vi(t)/S
P
i (t) where vi(t) down-weights small S
P
i (t).
5. Standardization
Methods of standardization that are used in the numerical sections of this paper are next
introduced, and discussed in relation to the criteria A1-5.
5.1 Stratification
The Ederer-II and Pohar-Perme estimators are often standardized by stratification, par-
ticularly by age group (Pokhrel and Hakulinen, 2008). The most common method is a
weighted arithmetic mean of stratum-specific estimates of the relative survival Rˆj in stratum
j = 1, . . . , k. Let gj = PH0(xi ∈ Gj) for groups Gj. Then denote the traditional standardized
statistic by
Dg(R) =
k∑
j=1
gjRj. (7)
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Dg satisfies A1-A3 provided the statistic Rj satisfies A1-A3 in each stratum. Note also that
when the same level of stratification is used for the weights in Rˆ1w and for weights in the
standardization (i.e. if wi(t) = wi′(t) whenever the observations i and i
′ come from the same
stratum Gj), then Dg(Rˆ
1
w) does not depend on the particular weights since the wi(u) terms
in (2) cancel out. Thus when the same factors are used to stratify the population mortality
SP and for standardization by stratification, the standardized Ederer-II (corresponding to
wi = 1) and the standardized Pohar-Perme (corresponding to wi = 1/S
P
i ) estimators will be
identical.
5.2 Baseline weighting
A problem with stratification is that the number in each stratum needs to be sufficient
to obtain an estimate of Se over the follow-up period of interest: with censored data it
is not possible to estimate the excess survival beyond the smallest of the stratum-specific
last follow-up times. A second approach to standardization is to use a weighted estimator.
Each individual is weighted so that the weighted sample at baseline represents the standard
population (Brenner et al., 2004). This approach corresponds to using time-constant weights
within the estimator, rather than taking a weighted average of stratum-specific estimates.
It is exactly what needs to be done to ensure that our condition A3 is satisfied. When used
with Ederer-II then one has weights (nzi)/ni, where ni =
∑n
j=1 I(xj = xi) is the number of
individuals in the sample at baseline with the same assumed covariate values, and zi is a
standard probability mass function for the covariates (
∑n
i=1 zi = 1). When this approach is
applied to the Pohar-Perme estimator one has
wBi (t) =
nzi
SPi (t)ni
. (8)
Unlike the usual Pohar-Perme estimator these weights this satisfy A3 for both Rˆ1w and Rˆ
2
w,
but they are similarly not robust.
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5.3 Standardized relative survival
Our proposal is to standardize the estimators of R1w and R
2
w by using weights
wi(t) =
nziS
0
i (t)
SPi (t)ni
. (9)
If the covariate distribution at time 0 is zi and individuals are subject to survival S
0
i (t), then
ziS
0
i (t) will be the covariate distribution at time t in the standard population. Thus ziS
0
i (t)
can be thought of as a standard prevalence of patients with the disease and covariates xi at
time t post diagnosis. The limit of the estimators with these weights corresponds to R1w and
R2w with w = h
0S0/(SPh). With these weights R1w and R
2
w meet A3 as described above. The
parameterization is still arbitrary, in that S0 and H0 (or zi) may be chosen, but A4 helps
to rule out certain choices of S0. For example, if H0 = H and S0(t) = 1 for all t then R1w is
the Pohar-Perme estimator which does not meet A4. Suppose that X = (age, l) where l is
a categorical variable with l = 1, 2, . . . , L levels, and SP (t | a, l) = SPbl (a + t), where SPbl is
the survival from birth in group l. Then to meet A4 we showed that the standard reference
weights should be chosen so that S0bl(t) 6 SPbl (t) for all l and t. For instance, a country with
the poorest population survival could provide S0.
Equations (5) and (6) show how the choice of S0 in (9) relates to A5. The proposed
weight wi(t) = h
0(xi)S
0
i (t)/{h(xi)SPi (t)} enables us to ensure S0i (t)/SPi (t) is stable through
the choice of S0. Equations (5) and (6) also show that there may be a trade-off between
robustness and precision. If wi(t) is zero then the data from individual i will not be used for
estimation at time t; this will give the estimator robustness against outlying events at time
t, but (5) will be larger and precision worse. Thus one would not wish to set S0(t | x) to zero
for t > T unless there is no interest in estimating R at or beyond time T .
In summary, we have two measures and estimators that satisfy criteria A1-A4, under an
assumption of independent censoring. It is not clear whether there are circumstances when
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one might dominate the other in terms of estimation precision (A5). This will be explored
later using a computer simulation.
To help interpretation note that when S0 = SP and h0 = h, the weights in (9) equal one.
Thus R2w and R
1
w are respectively the Ederer-I and II estimation targets when the standard
survival is taken to be the same as that in the reference population, and the standard
covariate distribution is the same as in the observed cohort. Suppose instead that SP = 1
(i.e. there is no competing hazard) then both Ederer-II and Pohar-Perme weights in R1w are
one, and Rˆ1w gives the Kaplan-Meier estimator (more precisely Aˆw gives the Nelson-Aalen
estimator). The use of S0 in our weights (9) provides a stratum-weighted Kaplan-Meier
estimator (Xie and Liu, 2005). Thus R1w with weights given by (9) can be interpreted as
the marginal net survival that would be observed in population H0 subject to censoring
S0(t | x). It might be called the S0-filtered net survival. At each time t, R1w corresponds to a
weighted average of the conditional excess hazard functions: EH0{w(t,X)λe(t | X)}, where
EH0{w(t,X)} = 1. If the excess hazard is independent of X then the weights do not matter.
More generally we want the weights to be reasonably homogeneous. In particular we would
like to give (approximately) equal weight to subset of X that have equal probability of being
at risk at time t. Ederer-II does this exactly but at a price - it does not satisfy A2. Our
weights (9) provide a good approximation to homogeneous weighting while ensuring A1-A3
hold.
6. Example
The R package relsurv (Perme, 2013), which implements the Pohar-Perme, Ederer-II and
some other relative survival estimators was extended to fit the standardized methods in this
report (supplementary material). To demonstrate the methods we obtained data on breast
cancers diagnosed between 1973 and 2010 in the USA from SEER (2014). Death rates for
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the same period were obtained from National Center for Health Statistics (2015) by age and
gender. The following reference data were used for standardization.
(1) The reference age distribution of cases was a standard taken from Corazziari et al. (2004).
This weights age groups (15-44, 45-54, 55-64, 65-74, 74+) as (7, 12, 23, 29, 29)%.
(2) For exposition the standard reference mortality rate was taken to be that estimated
for the Russian Federation (Human Mortality Database, 2016), where mortality rates
were approximately 70% higher than in the USA for women aged 60 between 1980-1989,
rising to 300% by 2000-2010. The effect of a lower reference rate (not recommended) was
considered by dividing the USA mortality rates by three.
We focus on the survival of 16597 women younger than 85 who were diagnosed with invasive
breast cancer with distant spread (stage 4 based on SEER historic stage A), between 1980
and 2010, of whom 15572 died after a median follow-up of 7.9 years.
Figure 1 shows the Pohar-Perme relative survival estimates by age band, where there was
little difference to 10-years between the younger (< 55) and older groups. Thus to 10-years
net survival appeared to be almost independent of age at diagnosis (c.f. criteria A1). However,
beyond ten-years the differences become more pronounced for the 75+ group, as competing
mortality rates increased and precision decreased. This had an impact on the traditional
age-standardization estimate, as this age group is weighted most highly.
Figure 2 compares un-standardized and standardized estimates. To ten years where there
was very little difference in net survival by age, there was very little practical difference be-
tween the estimators; only a very small difference is visible between the stratified estimators
and the others. Larger differences were seen after 10-years. Traditional age-standardization
of Pohar-Perme or Ederer-II yielded very similar estimates, with substantial variability. The
Brenner age-adjustment of Pohar-Perme was close to un-standardized Pohar-Perme. Our
proposals (with a reference mortality that is higher than in the USA) were less variable and
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closer to un-standardized Ederer-II than the others. Reference rates lower than the USA are
only shown for insight and are not recommended; as expected these weights yield an estimate
with properties somewhere between those of the Pohar-Perme and Ederer-II estimates.
[Figure 1 about here.]
[Figure 2 about here.]
7. Two-group simulation
A computer simulation with the following characteristics was used to further compare the
estimators. Mortality rates in cohort 1 were based on women in the USA in 1980, in cohort 2
they were (i) 1.2 times higher for those younger than 70, (ii) two times higher for those aged
70-85, and (iii) four times higher when aged 86 or older. The standard reference population
rates were (i) two times higher for those younger than 70, (ii) 4 times higher for those aged
70-85, and (iii) 100 times higher when aged 86 or older, to reflect a standard population
where very few people lived into their 90s. The excess hazard was the same in both cohorts,
being 3% greater per year from age 65. There were two groups in each population aged
65 or 75 at diagnosis. The percentage aged 65 at diagnosis was 60% for cohort 1, 70% for
cohort 2, and 50% in the standard reference population. There were two censoring scenarios:
(i) no censoring, and (ii) uniform censoring between 1 and 25 years. In the first cohort
approximately 41% were censored before their event time, and 35% in the second cohort.
The outcomes of interest were estimates of relative survival at 5, 10, 15 and 20-years. A
group of 2000 individuals was simulated 5000 times from both cohort populations.
Standardization is needed or methods will show a difference between the cohorts that only
reflects their age distribution at baseline; we used the methods from Section 5.
We focus first on the simulations without censoring. Figure 3 shows boxplots of the simula-
tion survival estimates, and summary statistics are given in Table 1. The plots highlight that
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the net and standardized survival in the reference population are different quantities. Our
interest is not in a comparison of how well the estimator for standardized survival recovers
net survival etc, but whether one would draw an appropriate conclusion when comparing
the two cohorts. For this the plots show little difference to 10-years. All the estimators had
only small bias, and the right conclusion would be drawn for all the estimators. However, at
5 and 10-years, standardized relative survival R1 and R2 were more precise than net survival
in terms of Var(Rˆ)R−2 (Table 1), so they would rule out larger differences because they are
more precise.
Beyond 10 years the net survival estimators started to break down, showing differences
between the cohorts even though the age-specific excess hazards are identical. This is reflected
by substantial differences between estimates of net survival in the second cohort compared
with the first. The reason accounts for the lack of results for traditional standardization at
20-years survival, where it was not possible to estimate relative survival in the second cohort
because everyone in the older group was dead. This robustness issue likewise affected the
Brenner baseline standardization method. Our standardization methods performed robustly
even at 20-years, as the standard reference population effectively excluded everyone once
they were older than 85.
Censoring decreased the precision of all estimators, but did not appear to affect Rˆ1w very
much more than Rˆ2w. To five years Rˆ
1
w had slightly better precision than Rˆ
2
w. Beyond that, it
was very similar to Rˆ1w for no censoring, and slightly worse with censoring in cohort 2: there
was not a clear winner between Rˆ1w and Rˆ
2
w in these simulations.
[Figure 3 about here.]
[Table 1 about here.]
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8. Discussion
In this article we outlined some criteria for relative survival, and then assessed different
families of measures. We developed two new measures and estimators that met our criteria.
Standardized R1 may be interpreted as the marginal net survival that would be ‘observed’
in a standard population subjected to standard censoring. This is because it provides the
survival transform of a weighted excess hazard: viewing the weights as the probability of
being at risk in the standard population (at time t given covariate x) gives the interpretation
(provided that SC(t) 6 SP (t)). Standardized R2 targets a marginal probability of surviving
the excess hazard from the disease if the person would survive as long with respect to
the standard population. It has a similar interpretation to the stratified standardization
approach of Brenner and Hakulinen (2003), who proposed time-dependent weights of the
form S0j (t) in the context of stratified estimation (Pokhrel and Hakulinen, 2008). Here we
applied similar weights but to the individual subject, which follows the ideas in Brenner
et al. (2004), also incorporating the inverse probability of sampling weights introduced in
this context by Perme et al. (2012). Interpretation of R1w is arguably easier than R
2
w, because
the excess (non-cumulative) hazard and relative density functions corresponding to R1w do
not depend on the derivative of the weights with respect to time dw/dt, whereas for R2w
they do depend on the derivative dw/dt. However, both are statistical constructs. For a non-
specialist audience we suggest to describe both proposals as standardized relative survival
indicies designed to accurately and precisely determine the direction and ordering of survival
differences between cohorts.
Standardized R1 and R2 may be applied for longer follow-up than traditional standardiza-
tion, by placing more weight on those young enough to be expected to survive that long after
diagnosis. But, they are not consistent estimators of the marginal net survival. In our view
this is much less important than our other criteria. Indeed, whenever one uses a Pohar-Perme
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estimator that is standardized by stratification, one is already foregoing having an estimator
of the (unstandardized) net survival. More importantly, any measure of relative survival that
is not the same when the excess hazard given covariates is the same in two populations, seems
more deficient than one which is inconsistent for estimation of the marginal net survival. We
do not accept the need to only estimate the marginal net survival, and would prefer to
precisely estimate the mean net survival with respect to a standard covariate distribution.
Our argument mirrors Bickel and Lehmann (1975), who showed that although a trimmed
mean is not an unbiased estimate of the mean of an asymmetric distribution, it has a place
as a measure of central location of a distribution, and may be better for this than the mean
in many situations.
This paper has considered properties of relative-survival measures and estimators, and
from this some general guidance was provided on how to choose the standardization weights.
More practically, it would be useful to provide investigators recommended tables of standard
weights. We will develop elsewhere recommended cancer-site specific standardization tables
for our methods. Another limitation is that we have not considered dependent censoring
patterns, such as those described by Hakulinen (1982); Kodre and Perme (2013). Future work
will address this and testing differences between standardized relative survival estimates.
In conclusion, we hope that the criteria developed to assess relative survival measures and
estimators are useful for a theoretical understanding of their properties. We recommend that
our proposed standardization methods be considered for non-parametric relative survival
estimation, when the aim is to make comparisons between cohorts, such as from different
countries or periods in time, or even between disease types.
Supplementary Materials
An R package implementing the new methods is available with this paper at the Biometrics
website on Wiley Online Library.
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Figure 1. Pohar-Perme net survival estimates by age band and age-standardized: (a) to ten
years; (b) beyond ten years. PPa, traditional age-standardization; PPb, age standardization
based on (8).
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Figure 2. Estimated relative survival curves from example: (a) to ten years; and beyond ten
years for (b) some existing methods and (c) proposed estimators with reference to Ederer-II.
E2, Ederer-II estimate; PP, Pohar-Perme estimate; PPa, E2a, traditional age-standardization
from (7); PPb, Brenner age standardization from (8); R1S, proposal Rˆ1w with (9) and standard
reference mortality from the Russian Federation; R1S*, as R1S but with standard mortality
rates three times lower than the USA; R2S, proposal estimated by Uˆw from (4) with standard
rates from the Russian Federation; R2S*, similarly but with standard rates three times lower
than the USA.
Standardized relative survival 23
PP
a
[1]
PP
a
[2]
PP
b[1
]
PP
b[2
]
R
1S
[1]
R
1S
[2]
R
2S
[1]
R
2S
[2]
0.
2
0.
4
0.
6
0.
8
1.
0
(a) 5yr
Su
rv
iva
l
PP
a
[1]
PP
a
[2]
PP
b[1
]
PP
b[2
]
R
1S
[1]
R
1S
[2]
R
2S
[1]
R
2S
[2]
0.
2
0.
4
0.
6
0.
8
1.
0
(b) 10yr
Su
rv
iva
l
PP
a
[1]
PP
a
[2]
PP
b[1
]
PP
b[2
]
R
1S
[1]
R
1S
[2]
R
2S
[1]
R
2S
[2]
0.
2
0.
4
0.
6
0.
8
1.
0
(c) 15yr
Su
rv
iva
l
PP
a
[1]
PP
a
[2]
PP
b[1
]
PP
b[2
]
R
1S
[1]
R
1S
[2]
R
2S
[1]
R
2S
[2]
0.
2
0.
4
0.
6
0.
8
1.
0
(d) 20yr
Su
rv
iva
l
Figure 3. Estimated standardized relative survival from simulation example at: (a) five, (b)
ten, (c) 15 and (d) 20 years. The true net (— —) and standard survival statistics (··· R1w, – · –
R2w; both with weights (9)) in the reference population are given; samples are from two cohort
populations [1] and [2]. Net survival estimates are from PPa, traditional standardization
applied to Pohar-Perme estimation, and PPb which is Brenner standardization from (8).
The standardized survival estimates R1w and R
2
w with weights (9) are labelled respectively
R1S and R2S.
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Table 1
Summary results from simulation. Net survival estimates are from PPa, traditional standardization
(7) applied to Pohar-Perme estimation; PPb, Brenner standardization of Pohar-Perme estimation
from (8); R1S, standardized survival based on (9); R2S, standardized survival based on (9); [1],
first cohort; [2], second cohort; SD, standard deviation of estimates Rˆ i.e.
√
var(Rˆ); ****results
could not be estimated in some simulations, so summary statistics excluded.
Without censoring With independent censoring
Mean SD Var(Rˆ)R−2 Mean SD Var(Rˆ)R−2
bias (%) (×100) (×10000) bias (%) (×100) (×10000)
(a) 5-yr
PPa[1] -0.1 1.1 1.7 0.0 1.2 1.7
PPb[1] 0.0 1.1 1.7 0.0 1.2 1.7
R1S[1] 0.0 1.0 1.2 0.0 1.0 1.3
R2S[1] -0.1 0.9 1.0 -0.1 1.0 1.2
PPa[2] -0.1 1.7 3.7 -0.2 1.8 4.0
PPb[2] -0.1 1.7 3.7 -0.1 1.8 4.0
R1S[2] 0.0 1.3 2.1 -0.1 1.3 2.2
R2S[2] -0.1 1.0 1.3 -0.1 1.1 1.4
(b) 10-yr
PPa[1] -0.1 1.7 5.5 -0.1 1.9 7.4
PPb[1] -0.1 1.7 5.5 0.0 1.9 7.5
R1S[1] -0.1 1.5 3.7 0.0 1.7 4.7
R2S[1] -0.2 1.6 3.7 -0.1 2.1 6.3
PPa[2] -0.5 2.9 16.4 -0.5 3.3 21.2
PPb[2] -0.3 2.9 16.5 -0.3 3.3 21.5
R1S[2] -0.3 1.9 6.0 -0.3 2.1 7.4
R2S[2] -0.4 1.9 5.2 -0.3 2.2 7.2
(c) 15-yr
PPa[1] 0.0 2.0 15.8 0.0 2.6 26.6
PPb[1] 0.1 2.0 15.9 0.2 2.6 27.4
R1S[1] -0.2 2.0 9.4 -0.1 2.5 15.5
R2S[1] -0.3 2.1 9.6 -0.1 3.1 19.7
PPa[2] **** **** **** **** **** ****
PPb[2] 0.5 25.6 2586.3 -0.6 35.5 4955.4
R1S[2] -0.6 2.7 17.9 -0.6 3.5 30.0
R2S[2] -0.5 2.9 17.5 -0.6 3.8 30.7
(d) 20-yr
PPa[1] 0.3 2.1 47.8 **** **** ****
PPb[1] 0.7 2.1 49.6 0.7 3.8 161.2
R1S[1] -0.5 2.3 25.9 -0.5 4.0 76.0
R2S[1] -0.6 2.5 26.1 -0.7 4.5 83.6
PPa[2] **** **** **** **** **** ****
PPb[2] -11.9 23.1 5948.3 0.4 76.5 65030.4
R1S[2] -1.0 3.8 69.9 -1.3 6.4 198.1
R2S[2] -1.1 4.1 69.8 -1.6 6.9 201.5
